Minii markets branded active Pharmaceuticals and intermediates. The Company remains focused on ascending the value chain in the marketing of pharmaceutical substances and are determined to bring in increased revenues from dosage forms sales. Minii's diverse product basket encompasses a wide therapeutic mix.
Cardiovascular (CV) disease is the leading cause of mortality in India. In fact, a quarter of all deaths in the country can be attributed to this disease. Therefore, cardiovascular therapy becomes the second largest Therapy Area (TA) after anti-infective.
These help us in reinforcing our resolve towards providing a better life to patients. Our aim is to be a significant player in the cardiovascular TA by providing solutions for better management of this disease.
The third largest Therapy Area (TA) of the Indian Pharmaceutical Market (IPM) is Gastroenterology. It garners approximately 11% of the total Indian Pharmaceutical Market (IPM) value. With increasing innovations in this TA, the segment is set to grow significantly in the near future.
We have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhea, worm infestation etc.
This is one of Minii’s well-established Therapy Areas (TAs). In this TA, we will be establishing in feature amongst the topmost companies,
Our aim is to be a key player in the Diabetes Therapy by providing affordable solutions to millions of diabetics across India.
Pulmonary Arterial Hypertension Segment
